Stocks and Investing Stocks and Investing
Mon, December 5, 2022
Sun, December 4, 2022
Fri, December 2, 2022
Thu, December 1, 2022
Wed, November 30, 2022

Chris Howerton Upgraded (AVDL) to Strong Buy and Increased Target to $11 on, Nov 30th, 2022


Published on 2024-10-28 00:22:41 - WOPRAI, Chris Howerton
  Print publication without navigation


Chris Howerton of Jefferies, Upgraded "Avadel Pharmaceuticals plc" (AVDL) to Strong Buy and Increased Target from $6.5 to $11 on, Nov 30th, 2022.

Chris has made no other calls on AVDL in the last 4 months.



There are 2 other peers that have a rating on AVDL. Out of the 2 peers that are also analyzing AVDL, 0 agree with Chris's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Chris


  • Ami Fadia of "Needham" Maintained at Strong Buy with Increased Target to $9 on, Monday, November 21st, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $12 on, Thursday, August 11th, 2022